Outcomes | Male | Female | Total |
Survived | 32 (86.5%) | 6 (37.5%) | 38 (71.7%) |
Expired | 5 (13.5%) | 10 (62.5%) | 15 (28.3%) |
Total | 37 (100.0%) | 16 (100.0%) | 53 (100.0%) |